Qube Research & Technologies (QRT)
STRO icon

Qube Research & Technologies (QRT)’s Sutro Biopharma STRO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.11M Buy
379,290
+272,680
+256% +$6.02M 0.01% 1719
2026
Q2 		$3.54M Buy
+106,610
New +$3.32M ﹤0.01% 1806
2025
Q4 		– Sell
-6,523
Closed -$56.6K – 4067
2025
Q3 		$56.6K Sell
6,523
-5,017
-43% -$42.7K ﹤0.01% 3164
2025
Q2 		$82.4K Buy
+11,540
New +$94.4K ﹤0.01% 3068
2024
Q4 		– Sell
-6,890
Closed -$238K – 3800
2024
Q3 		$238K Sell
6,890
-171
-2% -$6.7K ﹤0.01% 2521
2024
Q2 		$207K Buy
+7,061
New +$279K ﹤0.01% 2416
2023
Q4 		– Sell
-495
Closed -$17.2K – 4712
2023
Q3 		$17.2K Buy
+495
New +$21.6K ﹤0.01% 3193
2023
Q2 		– Sell
-3,963
Closed -$183K – 2989
2023
Q1 		$183K Buy
+3,963
New +$251K ﹤0.01% 1961
2022
Q3 		– Sell
-2,930
Closed -$153K – 3009
2022
Q2 		$153K Buy
+2,930
New +$164K ﹤0.01% 1803
2022
Q1 		– Sell
-1,009
Closed -$150K – 2983
2021
Q4 		$150K Buy
+1,009
New +$181K ﹤0.01% 2051
2021
Q3 		– Sell
-1,534
Closed -$285K – 2747
2021
Q2 		$285K Buy
1,534
+389
+34% +$76.1K ﹤0.01% 1608
2021
Q1 		$261K Buy
+1,145
New +$272K ﹤0.01% 1526

Other funds holding STRO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s STRO Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Sutro Biopharma (STRO) stake by 256% in Q3 2026, buying an estimated $6.02M and bringing the position to 379,290 shares worth $6.11M. The position accounts for 0.01% of the portfolio, ranked #1719.

Qube Research & Technologies (QRT) first reported a position in STRO in Q1 2021 and has held it in 12 quarters since. 49 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Qube Research & Technologies (QRT) held 379,290 shares of Sutro Biopharma worth $6.11M as of Q3 2026.
  • Qube Research & Technologies (QRT) bought 272,680 Sutro Biopharma shares in Q3 2026, an estimated $6.02M.
  • Sutro Biopharma made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1719 holding.
  • Qube Research & Technologies (QRT) first reported a position in Sutro Biopharma in Q1 2021 and has held it in 12 quarters since.
  • 49 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.